Scientists test THC and Beta-Myrcene vapor in small human study
NCT ID NCT05432284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will give 32 healthy adults who use cannabis vaporized THC, beta-myrcene, or a placebo to see how these substances affect their feelings of being high and sleepy. Researchers want to learn how beta-myrcene, a compound found in cannabis and other plants, changes the body's response to THC. The study is not yet recruiting and is run by Johns Hopkins University.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
THC (cannabis) and beta-myrcene vapor
What this could lead to
If successful, this could help understand how beta-myrcene changes the effects of THC, potentially leading to better-informed cannabis use.
What could go wrong
This is a very early Phase 1 study with only 32 participants, so results may not apply broadly. It measures subjective effects, not real-world outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins School of Medicine Behavioral Pharmacology Research Unit
Baltimore, Maryland, 21224, United States